Form 4: Thermo Fisher Scientific Inc.: Director Jennifer M. Johnson Reports Acquisition of Common Stock
SEC Filing
Director Jennifer M. Johnson reported acquiring 339 shares of Thermo Fisher Scientific Inc. common stock on May 22, 2024.
Summary
- On May 22, 2024, Jennifer M. Johnson, a director of Thermo Fisher Scientific Inc., acquired 339 shares of common stock.
- The transaction was reported on a Form 4 filing with the SEC.
- Johnson also serves as the President, Chief Executive Officer, and a Director of Franklin Resources, Inc.
- Johnson disclaims beneficial ownership of Thermo Fisher Scientific securities held by Franklin Templeton subsidiaries.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to the market.
Stakeholder Impact
- The acquisition of shares by a director could be viewed positively by shareholders, signaling confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 05/22/2024 | Date of transaction: Jennifer M. Johnson acquired 339 shares of Thermo Fisher Scientific Inc. common stock. |
| 05/23/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.